WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s share price was down 1.1% during mid-day trading on Wednesday . The stock traded as low as $15.38 and last traded at $15.40. Approximately 2,627 shares traded hands during trading, The stock had previously closed at $15.58.
WisdomTree BioRevolution Fund Stock Performance
The firm has a market capitalization of $2.28 million, a P/E ratio of 16.52 and a beta of 1.18. The business’s fifty day moving average price is $16.82 and its two-hundred day moving average price is $15.92.
Institutional Trading of WisdomTree BioRevolution Fund
A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Flow Traders U.S. LLC increased its stake in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 15.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,700 shares of the company’s stock after purchasing an additional 12,679 shares during the period. Flow Traders U.S. LLC’s holdings in WisdomTree BioRevolution Fund were worth $1,627,000 as of its most recent filing with the Securities & Exchange Commission.
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Read More
- Five stocks we like better than WisdomTree BioRevolution Fund
- Election Stocks: How Elections Affect the Stock Market
- Comprehensive Analysis of PayPal Stock
- What is an Earnings Surprise?
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- What is a Secondary Public Offering? What Investors Need to Know
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.